Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatoma

Existing therapies such as irradiation or sorafenib have limited success in the treatment of hepatocellular carcinoma (HCC) due to tumor recurrence and metastasis. Therefore, combination with other therapeutics is often considered. Macrophage inflammatory protein-1 alpha (MIP-1α) is a member of a fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Keun-Yeong, Lee, Eun-Jung, Yang, Seung-Hyun, Seong, Jinsil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572594/
https://www.ncbi.nlm.nih.gov/pubmed/25225286
http://dx.doi.org/10.1093/jrr/rru077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572594/
https://www.ncbi.nlm.nih.gov/pubmed/25225286
http://dx.doi.org/10.1093/jrr/rru077

Ejemplares similares